Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

3 Growth Stocks That Also Pay Monthly Dividends: October 2023

By Josh Enomoto, InvestorPlace Contributor

With investors possibly facing difficult circumstances in the economy, now’s the time to consider growth stocks that pay monthly dividends.

7 Cryptos on a Tantalizing Comeback Surge

By Josh Enomoto, InvestorPlace Contributor

Although cryptos stormed higher thanks to speculation about a Bitcoin ETF approval, investors should use a levelheaded approach.

Silent Movers: 7 Under-the-Radar Tech Stocks You Need to Start Watching

By Josh Enomoto, InvestorPlace Contributor

With so many high-flying innovators feeling some corrective heat, now’s the time to consider under-the-radar tech stocks.

ACHR Stock Alert: Archer Aviation’s Class Action Lawsuit Dismissed

By Josh Enomoto, InvestorPlace Contributor

Although Archer Aviation popped on a class-action suit dismissal, ACHR stock will still need legal winds to act quickly.

Why Is LianBio (LIAN) Stock Up 130% Today?

By Josh Enomoto, InvestorPlace Contributor

With LianBio inking a key exclusive licensing agreement with Bristol-Myers Squibb, LIAN stock is jumping up on the credibility implications.

Load More